The treatment principle for elderly upper gastrointestinal bleeding is mainly to stop bleeding and treat the primary disease.
I. General management
1. Large amount of bleeding: Strengthen nursing care, fast, rest in bed, and maintain an unobstructed respiratory tract. Oxygen therapy, record urine output and blood loss, closely observe consciousness, body temperature, pulse, respiration, blood pressure, skin color, and venous filling, and if possible, perform electrocardiogram and blood pressure monitoring. If necessary, measure the central venous pressure.
2. Moderate or small amount of bleeding: Provide corresponding nursing, observation, and monitoring based on the amount of bleeding, age, and accompanying diseases; patients with hematemesis or variceal bleeding should fast, while other patients can generally eat a small amount of liquid or semi-liquid food.
II. Blood volume supplementation
The elderly have poor tolerance to ischemia, and blood volume supplementation should be more proactive, with blood transfusion indications relatively relaxed. After a large or moderate amount of bleeding, it is necessary to establish a venous access as soon as possible and to input an adequate amount of whole blood (fresh blood is preferable for patients with liver cirrhosis). It is best to adjust the fluid intake based on the central venous pressure to avoid pulmonary edema caused by excessive fluid intake. Patients with liver cirrhosis should be vigilant against rebleeding due to excessive blood transfusion and increased portal vein pressure.
Three, Hemostasis
1. Esophageal and gastric variceal bleeding:
① Somatostatin: Octreotide (Sandetide, somatostatin octapeptide) can be used, with an initial intravenous injection of 100μg, followed by an intravenous infusion of 25μg per hour, lasting for 72 hours. It can reduce visceral arterial blood flow, lower portal vein pressure, reduce the pressure and blood flow of esophageal and gastric varices, and achieve rapid hemostasis. The hemostatic rate is 70%-87%. Adverse reactions are rare.
② Neurohypophyseal hormone: It can also reduce portal vein pressure and achieve hemostasis, which has been the main treatment drug for this disease in the past. However, it has many adverse reactions, can induce angina pectoris, arrhythmias, etc., and is not suitable for the elderly. It can only be used cautiously when there are economic or other constraints and there is no alternative. It is contraindicated in patients with heart disease and hypertension. When used in combination with nitroglycerin, adverse reactions can be significantly reduced, and the recurrence rate of bleeding can be reduced.
③ Compression hemostasis with three-cavity balloon tube: This has been the main method of treatment for this disease in the past, with a short-term efficacy of about 80%, but a high incidence of rebleeding in a short period of time, and patients are relatively painful. It is necessary to be cautious of complications such as mucosal necrosis due to compression, balloon slipping and blocking the throat, aspiration pneumonia, etc. Now, it is often used in combination with octreotide (Sandetide) when satisfactory hemostasis is not achieved with octreotide.
④ Endoscopic treatment: Endoscopic ligation, a simple method with good efficacy and few complications; injection of sclerosing agents into varicose veins under endoscopy has an overall effective hemostasis rate of 85.4%, but can cause complications such as esophageal ulcers, pleural effusion, mediastinitis, etc. It is only suitable for high-risk patients who are not suitable for surgery and have failed other methods.
⑤ Surgical treatment: Suitable for those who have poor response to medical treatment and are allowed to undergo surgery.
⑥ Other: Hemostatic agents such as thrombin (Lishizhi) and antisecretory drugs such as omeprazole (Losec) can be helpful in accelerating hemostasis and preventing rebleeding.
2. Other upper gastrointestinal bleeding:
① Antisecretory drugs: Inhibit the secretion of gastric acid, inhibit the self-digestion of mucosal tissue by gastric acid and pepsin; reduce the local pH value, which is conducive to the aggregation of platelets and the formation of blood clots at the bleeding site. It is the most basic treatment method for most upper gastrointestinal bleeding, and a considerable number of patients can stop bleeding after antacid treatment. Proton pump inhibitors such as omeprazole (Losec) can be used, 40mg intravenous injection, 1-2 times a day, or 40mg intravenous infusion, and after bleeding control, it can be changed to oral administration. It has strong acid-suppressing effect, few adverse reactions, and a hemostatic rate of over 90% for peptic ulcers. H2 receptor antagonists such as cimetidine, ranitidine, and famotidine can also be used, initially administered intravenously and then changed to oral administration after the condition improves.
② Vasopressors: 6-8mg of norepinephrine, mixed with 30-100ml of normal saline for oral administration, 1 time every 6-8 hours, with rapid onset. Absorption is low, metabolism is fast, so it does not affect heart rate or blood pressure. However, be cautious of ischemic damage to the mucosa of the digestive tract. Methods such as lavage with ice water, oral administration of Mension's solution, or spraying under endoscopy have similar effects.
③ Somatostatin: Oxtreotide (Sandet) 100μg can be administered subcutaneously, once every 8 hours. It can also be administered intravenously or intravenously in case of necessity. It has multiple effects such as inhibiting gastric acid, promoting gastrin and pepsin, reducing visceral blood flow, and protecting the gastric mucosa, with a hemostasis rate of 87% to 100% for peptic ulcers and acute gastric mucosal lesions. Considering the cost factor, it can be used when bleeding is severe and other internal medicine methods are ineffective.
④ Hemostatic agents: Locally, thrombin, Yunnan Baiyao, Atractylodes macrocephala preparations, and Polygonum cuspidatum preparations can be used. Systemically (intravenous, intramuscular) can be used with batroxobin (Lizhi). Frozen thrombin complex is used for those with coagulation mechanism disorders. The efficacy of other hemostatic agents such as phenolsulfonate (hemostatic agent) is not certain.
⑤ Endoscopic hemostasis: There are methods such as spraying hemostatic agents, local drug injection, high-frequency electrocoagulation hemostasis, laser hemostasis, and microwave hemostasis. In elderly upper gastrointestinal bleeding, due to the presence of vascular sclerosis, bleeding may be persistent or recurrent. At this time, high-frequency electrocoagulation or laser can be considered, but indications should be strictly controlled and complications such as arterial hemorrhage and perforation should be prevented.
⑥ Surgical treatment: Surgery can be considered in cases with perforation, pyloric obstruction, malignant tumors, or when internal medicine methods cannot stop bleeding. Since the development of internal medicine is fast and the choice is wide, and there is a risk of postoperative residual gastric cancer and other lesions, surgery should be decided with caution.
4. Other treatments
1. Management of secondary lesions: Acute renal failure, treated as acute renal failure caused by shock. Appropriate treatment is given for infections, hepatic encephalopathy, etc. For anemia after hemorrhage, iron supplements and appropriate increase in protein nutrition can be supplemented, and the recovery is generally fast after bleeding stops. Polysaccharide iron complex (Lifengneng) is a non-ionic iron preparation in chelated state, with small dosage, complete absorption, and few adverse reactions; oral administration of 150mg, once a day. Severe anemia in the elderly may worsen existing heart, brain, and kidney damage, and red blood cell transfusion should be considered when necessary.
2. Treatment of primary lesions
3. Treatment of associated lesions: The elderly often have underlying diseases of important organs such as the heart. After gastrointestinal bleeding, these associated lesions may be interrelated with hemorrhagic damage and affect the evolution of the disease. Therefore, in the treatment and rescue of gastrointestinal bleeding, attention should be paid to the treatment of associated lesions such as heart disease, which often becomes the key to the success of rescue.